FDA to review data on possible carcinogens in Coke, Pepsi

Image
ANI Washington
Last Updated : Jan 24 2014 | 3:20 PM IST

The FDA is reportedly planning to assess data on possible presence of chemical 4-MeI, a carcinogenic byproduct, produced at the time of manufacturing of caramel colored soda, after a Consumer Reports test indicated higher levels of carcinogen in sodas selling across the U.S.

Consumer Reports and Johns Hopkins Center for a Livable Future joined hands to test samples of soda brands for 4-MeI levels in California and New York twice last year.

A California measure was used to test brands like Pepsi, Coca-Cola, and Malta Goya, out of which, Malta Goya reported ten times more carcinogen than the accepted amount, reaching up to 300 micrograms, Verge reported.

Meanwhile, FDA continues to maintain that there is no reason to believe the compound is unsafe. However, it did say that it will look into the matter.

In 2007, the National Toxicology Program, a branch of the US Department of Health and Human Services had said that the 4-MeI substance that caused cancer in mice could be "possibly carcinogenic" to humans.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 24 2014 | 3:04 PM IST

Next Story